Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 3425 - 3432 of 12142 results

Hearings on the SolarWinds Hack and Possible Policy Responses

March 4, 2021| Blog| Viewpoint

Tracking the Vaccinated by Name, Race Challenges Privacy Laws

March 4, 2021| News

FDA Releases Definitive Statement on Fake Registration Certificates

March 4, 2021| Blog| Viewpoint

Rosenworcel Positions Herself to Be First FCC Female Chair

March 4, 2021| News

Agencies Issue Needed Guidance on COBRA Elections During the COVID-19 “Outbreak Period”

March 3, 2021| Blog| Viewpoint

Virginia Passes Comprehensive Data Privacy Law – Mintz’s Hot Take

March 3, 2021| Blog| Viewpoint

NPM Podcast - Episode 1: Judy Kwok | Mintz

March 3, 2021| Podcast| Viewpoint

What's New in 5G - March 2021

March 2, 2021| Blog| Viewpoint

News & Press Releases

Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash

September 16, 2025

Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.

Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber

September 15, 2025

Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering

September 12, 2025

Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”

View all News and Press Releases